1. A 6-Aminoquinolone Compound, WC5, with Potent and Selective Anti-Human Cytomegalovirus Activity
- Author
-
Arianna Loregian, Giorgio Palù, Beatrice Mercorelli, Oriana Tabarrini, Elisa Sinigalia, Maria Angela Biasolo, Violetta Cecchetti, and Giulia Muratore
- Subjects
Pharmacology ,Human cytomegalovirus ,Molecular Structure ,viruses ,Congenital cytomegalovirus infection ,Cytomegalovirus ,virus diseases ,Biological activity ,Biology ,Virus Replication ,medicine.disease ,medicine.disease_cause ,biology.organism_classification ,Antiviral Agents ,Virology ,In vitro ,Herpesviridae ,Virus ,Infectious Diseases ,Viral replication ,Aminoquinolines ,medicine ,Humans ,Pharmacology (medical) ,Human herpesvirus 6 - Abstract
We identified a 6-aminoquinolone compound, WC5, that inhibits human cytomegalovirus (HCMV) replication with a selectivity index of ∼500. WC5 also showed activity against drug-resistant HCMV strains. In contrast, it did not significantly affect the replication of human herpesvirus 6 and 8 and was ∼10-fold less active against murine cytomegalovirus. Thus, WC5 may represent a lead for the development of new, potent, and selective anti-HCMV compounds.
- Published
- 2009
- Full Text
- View/download PDF